The Skin Care Foundation Honors BASF and Energizer
The BASF Team, pictured top, left to right: John Helfrick, director global key account manager, NA; Gary Dee, director, home and personal care, NA; Laura Partynski, marketing communications manager; Gabriel Tanbourgi, president, BASF care chemicals; Sabine Malley, industry manager, skin and sun care; Samantha Hetherington, regional sales manager, home and personal care; and Simon Medley, senior vice president, care chemicals and formulations, NA. Bottom, left to right (seated): Lisa Weber, head of quality, care chemicals, NA; Frank Freiler, vice president, beauty care solutions; Adel Collado, marketing manager, home and personal care; and Adrian Johnson, product manager, UV filters.
The Skin Cancer Foundation hosted its Annual Skin Sense Award gala on Oct. 12, New York’s Pierre Hotel. The event honored BASF Care Chemicals and Energizer Personal Care for their accomplishments in skin care and skin cancer prevention, and recognized the support of the 400 attendees representing skin care, beauty, cosmetics, fragrance, the pharmaceutical industries and dermatological sciences.
Vivimed Labs Expands U.S. Presence
Vivimed Labs Ltd., Hyderabad, India, recently established Vivimed Labs USA, Inc. According to the company, dramatic internal growth and the acquisitions of James Robinson Ltd. in May 2008 and Har-Met in October 2009, prompted Vivimed Labs Ltd. to open a U.S.-based sales office in New Jersey.
The unit’s product base includes antimicrobials, sun filters, hair care products and hair dye ingredients. Products are currently being warehoused in Bridgewater, NJ as well as in Greensboro, NC.
The new office is located 1100 Cornwall Road, Suite 160, Monmouth Junction, NJ 08852. The phone number is (732) 398-0008 and the fax number is (732) 398-0013. The company can be reached by e-mail at sales-USA@vivimedlabs.com
Rhône Capital Sells Stake In Arizona Chemical
Rhône Capital has entered into a definitive agreement to sell a controlling interest in Arizona Chemical to American Securities, a New York-based private equity firm. Terms of the agreement have not been disclosed.
The transaction, subject to regulatory approvals and customary closing conditions, is expected to close this year. Rhône, along with other current investors and the management team, will retain 25% of the company’s ownership and will continue to participate in its growth and development through pro rata representation on Arizona Chemical’s board of directors, according to a press statement released by Rhône.
“American Securities has a strong history of providing the leadership and resources necessary to ensure that the businesses that are part of their portfolio continue to achieve success,” explained Kees Verhaar, president and chief executive officer of Arizona Chemical. “We look forward to continuing to grow our business and strengthen our customer relationships under their leadership.”
American Securities’ portfolio includes General Chemical, MECS and Fairmount Minerals in the chemical markets.
Botaneco Signs Hydresia European Distributor
Botaneco has inked a deal with Seppic S.A for distribution of the Hydresia product line in the European personal care market.
“Global expansion is a key component of our value proposition and growth strategy,” said Botaneco’s president and chief executive officer Michael Stangel. “We are pleased that Seppic will be representing us and anticipate that together, we will significantly grow European sales in line with our objectives.”
Dr. Jack Guth, vice president research and development, added,“Hydresia ingredients are uniquely poised to take advantage of a European market where the percent share of natural and organic cosmetics is rising steadily. Oleosomes are Ecocert-compliant, have a true sustainability message, and provide myriad multi-functional attributes.”
“Sunscreen formulations are one of the most applicable categories for Hydresia ingredients because of the reduced whitening, and intrinsically low irritancy profile of oleosome-based formulations,” Guth concluded.
Fragrance Materials Association is Now IFRA North America
At its annual Fall workshop and luncheon in Teaneck, NJ, the Fragrance Materials Association announced its strategic realignment with the International Fragrance Association (IFRA) to become IFRA North America.
The event also marked the launch of the new website, www.ifrana.org, which contains in-depth information about fragrance industry and safety.
“IFRA North America has a strong 83-year history as the leading fragrance materials association in North America,” said Jennifer Abril, executive director.“Our new expanded global reach will serve not only our members, but also the public as we ensure the safety of fragrance ingredients and products through industry-wide compliance with the IFRA Code of Practice.”
The name change reflects the growing need of IFRA North America's members to leverage global resources to strengthen its voice in North America.
Solta Medical Acquires Maker of Claro Acne Device
Medical aesthetics company Solta Medical has acquired CLRS Technology, maker of the Claro device that uses heat and light to combat acne.
CLRS gives Solta Medical, which generated nearly $100 million in revenues last year through the sale of systems Fraxel and Thermage for dermatological procedures, an entrance into the OTC personal care segment. The company will assume approximately $1.1 million of CLRS’ debt at the deal’s closing and make future payments of undisclosed amounts based upon CLRS’ revenue and operating income through the end of 2011.
“We are the first home-use device company to be backed by a publicly traded company that is in the aesthetic marketplace,” said Richard Oberreiter, chief executive officer and founder of Costa Mesa, CA-based CLRS Technology. “What you have seen to date out there [in at-home devices] with the Zeno, Tanda, Tria and some other stuff is just the tip of the iceberg. We think that we are getting a real leg up with having a publicly traded company with deep research and development behind it to really make a splash.”
The Claro initially hit Nordstrom in October 2009 at $250, but a second-generation device with a $195 price tag is now rolling out. It has a slightly lowered heat output to reduce discomfort and new marketing materials that detail the sensation felt by Claro users.
Oberreiter said Sephora has made a commitment to carry the device in the first quarter of 2011.
Claro is the first acne treatment device sold at retailers that harnesses intense pulsed light (IPL) to receive approval from the U.S. FDA, according to CLRS.
To accommodate the rapid growth it has gone through during the pastdecade, DeWolf Chemical has moved its offices after 25 years in East Providence, RI. The new location, in nearby Warwick, RI, is a state-of-the-art facility that fits the current and future needs of the growing company, the company said.
The owners of the third-generation, family-run business recognized that a new office was necessary to not only accommodate their progressively increasing staff size, but to ensure that the high level of customer service the company is known for could be maintained.
“When we started 68 years ago, we had a different name, a different location, and sold to a different industry,” said Hank DeWolf, chief executive officer of DeWolf Chemical. “This move is a rewarding, tangible tribute to all of the hard work invested in this company over the past seven decades.”
No contact information, with the exception of the new address (300 Jefferson Blvd., Warwick, RI 02888), has changed. All phone numbers, fax numbers and email addresses remain the same, according to the company.